D. J. O’Reilly, R. A. Goeree, J.-E. Tarride, C. Janes, and P. S. Parfrey, “THE UNINTENDED (AND COSTLY) EFFECTS DUE TO THE INTRODUCTION OF AN UNRESTRICTED REIMBURSEMENT POLICY FOR ATYPICAL ANTIPSYCHOTIC MEDICATIONS IN A CANADIAN PUBLIC PRESCRIPTION DRUG PROGRAM: 1996/97 TO 2005/06”, J Popl Ther Clin Pharmacol, vol. 16, no. 2, Dec. 2018.